Subscribe To

Price Alert Latest News Economic Calendar News

MMNFF / Cannabis Retailer MedMen Extends Maturity Date Of Commercial Loan Agreement

Cannabis retailer MedMen Enterprises Inc. MMEN MMNFF, announced that it has extended the maturity date of the term and made certain other amendments to its commercial loan agreement, of an aggregate outstanding principal balance of approximately $114.3 million, dated as of October 1, 2018, entered into by its subsidiary MM CAN USA, Inc. The Amendments extend the stated maturity date of the term loans for a period of six months and provide that certain definitive documentation with respect to the conditional purchase of the term loans by a note holder under the company's senior secured convertible securities purchase agreement dated August 17, 2021 must be entered within 45 days or the stated maturity date of the term loans become due. Read More

Demo Live Account See Partner Details

Content Topics

Cannabis

Retailer

Medmen

Extends

Maturity

Date

Commercial

Agreement

Stock

MMNFF

Posted: Feb 2 2022, 08:41

Author Name: Benzinga

MMNFF News

By InvestorPlace
October 1, 2023

Ticking Time Bombs: 3 Cannabis Stocks to Dump Before the Damage Is Done

The North American cannabis market is booming in 2023, thanks to the legalization of recreational and medical marijuana in several states and province

By Forbes
July 5, 2023

Cannabis Pioneer MedMen Names Fifth CEO In 3 Years As Company Teeters On Brink Of Collapse

MedMen in 2018 became the first marijuana company to achieve a $1 billion valuation, but the company is now short on cash and is nearing collapse.

By Market Watch
July 5, 2023

MedMen appoints Ellen Deutsch as CEO

MedMen Enterprises Inc. CA:MMEN, the struggling U.S. cannabis retailer, on Wednesday appointed Ellen Deutsch as its new chief executive, and said Amit

By Market Watch
June 16, 2023

MedMen CFO Bowman resigns

Cannabis retailer MedMen Enterprises Inc. MMEN, on Friday announced the resignation of Chief Financial Officer Ana Bowman, effective June 29. Bowman h

By MarijuanaStocks
May 27, 2023

2 Marijuana Stocks On Watch Before June

Are you looking for the best marijuana stocks to buy before June? This month, bipartisan United States House and Senate lawmakers reintroduced the SAF

By MarijuanaStocks
May 25, 2023

Is It Time To Buy Cannabis Stocks? 2 Under $1 To Watch

Are you looking for the best marijuana stocks to buy at the end of May? This month, bipartisan United States House and Senate lawmakers resurrected th

By MarijuanaStocks
May 17, 2023

Are Penny Stocks On Your List For May? 3 Cannabis Stocks To Watch This Week

Are These Penny Pot Stocks On Your List For May? The post Are Penny Stocks On Your List For May? 3 Cannabis Stocks To Watch This Week appeared first o

By Market Watch
March 22, 2023

Cannabis exec Adam Bierman wins MedMen arbitration settlement and eyes pot biz again

Adam Bierman made a name for himself as a co-founder of MedMen in 2010 by modeling cannabis dispensaries after the Apple Store and later announcing wh

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.